Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.29 is 33% below its 5-year average of 12.40, near the low end of its 5-year range (8.29–25.13).
As of the fiscal period ended Tuesday, June 30, 2026. 15.94% below its 12-month average of 9.87.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.29.
CURRENT RATIO
8.29
CURRENT RATIO AVG TTM
9.87
CURRENT RATIO AVG 3Y
10.86
CURRENT RATIO AVG 5Y
12.40
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.94%
CURRENT VS 3Y AVG
-23.60%
CURRENT VS 5Y AVG
-33.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
+138.34%
vs the sector median at left
Market Cap
$5.08B
Current Ratio
4.20
TTM Avg
4.30
3Y Avg
4.12
5Y Avg
3.47
Market Cap
$5.21B
Current Ratio
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$5.23B
Current Ratio
13.57
TTM Avg
9.78
3Y Avg
9.13
5Y Avg
11.38
Market Cap
$5.27B
Current Ratio
17.85
TTM Avg
17.70
3Y Avg
17.06
5Y Avg
17.77
Market Cap
$4.90B
Current Ratio
2.86
TTM Avg
2.88
3Y Avg
3.29
5Y Avg
4.98
Market Cap
$4.84B
Current Ratio
38.51
TTM Avg
25.63
3Y Avg
37.00
5Y Avg
29.64
Market Cap
$4.85B
Current Ratio
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $5.08B | 8.29 | 9.87 | 10.86 | 12.40 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.08B | 4.20 | 4.30 | 4.12 | 3.47 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.21B | 7.02 | 8.28 | 8.59 | 7.77 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.23B | 13.57 | 9.78 | 9.13 | 11.38 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.27B | 17.85 | 17.70 | 17.06 | 17.77 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | 2.86 | 2.88 | 3.29 | 4.98 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | 38.51 | 25.63 | 37.00 | 29.64 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.85B | 26.10 | 14.27 | 14.23 | 14.47 |
| Doximity, Inc. (DOCS)vs › | $5.35B | 6.08 | 6.53 | 6.56 | 6.07 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.40B | 3.39 | 2.35 | 2.11 | 2.46 |
Current Ratio
8.29
Quick Ratio
8.29
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.29 |
| 2026-03-31 | 9.52 |
| 2025-12-31 | 10.04 |
| 2025-09-30 | 10.45 |
| 2025-06-30 | 11.04 |
| 2025-03-31 | 12.35 |
| 2024-12-31 | 9.84 |
| 2024-09-30 | 11.00 |
| 2024-06-30 | 16.79 |
| 2024-03-31 | 10.14 |
| 2023-12-31 | 12.26 |
| 2023-09-30 | 11.45 |
| 2023-06-30 | 13.90 |
| 2023-03-31 | 15.59 |
| 2022-12-31 | 9.13 |
| 2022-09-30 | 13.21 |
| 2022-06-30 | 17.09 |
| 2022-03-31 | 18.86 |
| 2021-12-31 | 16.02 |
| 2021-09-30 | 25.13 |
| 2021-06-30 | 11.01 |
| 2021-03-31 | 19.11 |
| 2020-12-31 | 8.77 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
